Mir-17-92 regulates bone marrow homing of plasma cells and production of immunoglobulin G2c

Nature Communications

Volumn 6, Issue , 2015, Pages

  Xu, Shengli ^a,b   Ou, Xijun ^a   Huo, Jianxin ^a   Lim, Kristen ^a   Huang, Yuhan ^a   Chee, Sheena ^a   Lam, Kong Peng ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2C; IMMUNOGLOBULIN M ANTIBODY; MICRORNA; MICRORNA 17 92; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G; MIRN17-92 MICRORNA, MOUSE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PTPN6 PROTEIN, MOUSE; S1PR1 PROTEIN, MOUSE; ZFPN1A1 PROTEIN, MOUSE;

BONE; GENETIC DIFFERENTIATION; GERM CELL; IMMUNE SYSTEM; PLASMA;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B CELL CULTURE; B LYMPHOCYTE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE DELETION; HEK293 CELL LINE; HISTONE ACETYLATION; IMMUNE COMPLEX NEPHRITIS; IMMUNE RESPONSE; IN VITRO STUDY; MEMORY CELL; MOUSE; NONHUMAN; PLASMA CELL; PRE B LYMPHOCYTE; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; CELL MOTION; FLOW CYTOMETRY; GENETICS; GLOMERULONEPHRITIS; IMMUNE COMPLEX DISEASE; IMMUNOLOGY; METABOLISM;

MUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; BONE MARROW; CELL DIFFERENTIATION; CELL MOVEMENT; FLOW CYTOMETRY; GLOMERULONEPHRITIS; IKAROS TRANSCRIPTION FACTOR; IMMUNE COMPLEX DISEASES; IMMUNOGLOBULIN G; MICE; MICRORNAS; PLASMA CELLS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, LYSOSPHINGOLIPID; T-LYMPHOCYTES;

EID: 84928136420     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7764     Document Type: Article

References (53)

1. Rajewsky, K. Clonal selection and learning in the antibody system. Nature 381, 751-758 (1996).
2. Goodnow, C. C., Vinuesa, C. G., Randall, K. L., Mackay, F. & Brink, R. Control systems and decision making for antibody production. Nat. Immunol. 11, 681-688 (2010).
3. Nutt, S. L. & Kee, B. L. The transcriptional regulation of B cell lineage commitment. Immunity 26, 715-725 (2007).
4. Mandel, E. M. & Grosschedl, R. Transcription control of early B cell differentiation. Curr. Opin. Immunol. 22, 161-167 (2010).
5. Xiao, C. & Rajewsky, K. MicroRNA control in the immune system: basic principles. Cell 136, 26-36 (2009).
6. de Yebenes, V. G., Bartolome-Izquierdo, N. & Ramiro, A. R. Regulation of B-cell development and function by microRNAs. Immunol. Rev. 253, 25-39 (2013).
7. Lee, Y. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060 (2004).
8. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419 (2003).
9. Hutvagner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834-838 (2001).
10. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
11. Koralov, S. B. et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132, 860-874 (2008).
12. Belver, L., de Yebenes, V. G. & Ramiro, A. R. MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33, 713-722 (2010).
13. Xu, S., Guo, K., Zeng, Q., Huo, J. & Lam, K. P. The RNase III enzyme Dicer is essential for germinal center B-cell formation. Blood 119, 767-776 (2012).
14. Ota, A. et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087-3095 (2004).
15. Tagawa, H. & Seto, M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19, 2013-2016 (2005).
16. He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005).
17. Jin, H. Y. et al. MicroRNA-17 B92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J. 32, 2377-2391 (2013).
18. Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875-886 (2008).
19. Kabashima, K. et al. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med. 203, 2683-2690 (2006).
20. Sellars, M., Reina-San-Martin, B., Kastner, P. & Chan, S. Ikaros controls isotype selection during immunoglobulin class switch recombination. J. Exp. Med. 206, 1073-1087 (2009).
21. Mavrakis, K. J. et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat. Genet. 43, 673-678 (2011).
22. Schmidt-Supprian, M. & Rajewsky, K. Vagaries of conditional gene targeting. Nat. Immunol. 8, 665-668 (2007).
23. Baumgarth, N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11, 34-46 (2011).
24. McHeyzer-Williams, L. J. & McHeyzer-Williams, M. G. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23, 487-513 (2005).
25. Tarlinton, D., Radbruch, A., Hiepe, F. & Dorner, T. Plasma cell differentiation and survival. Curr. Opin. Immunol. 20, 162-169 (2008).
26. Nie, Y. et al. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J. Exp. Med. 200, 1145-1156 (2004).
27. Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69-94 (2012).
28. Chiba, K. et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160, 5037-5044 (1998).
29. Brinkmann, V. et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457 (2002).
30. Zhang, Z., Goldschmidt, T. & Salter, H. Possible allelic structure of IgG2a and IgG2c in mice. Mol. Immunol. 50, 169-171 (2012).
31. Stavnezer, J., Guikema, J. E. & Schrader, C. E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26, 261-292 (2008).
32. Nambu, Y. et al. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302, 2137-2140 (2003).
33. Wang, L., Whang, N., Wuerffel, R. & Kenter, A. L. AID-dependent histone acetylation is detected in immunoglobulin S regions. J. Exp. Med. 203, 215-226 (2006).
34. Blanco, F. et al. IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases. Lupus 1, 391-399 (1992).
35. Tiikkainen, U., Wangel, A., Appleton, S. L. & Arthur, D. Subclasses of IgG anticardiolipin antibodies in patients with systemic lupus erythematosus. Scand. J. Immunol. 34, 265-271 (1991).
36. Martin, F. & Chan, A. C. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 20, 517-527 (2004).
37. Yung, S. & Chan, T. M. Anti-DNA antibodies in the pathogenesis of lupus nephritis - the emerging mechanisms. Autoimmun. Rev. 7, 317-321 (2008).
38. Pao, L. I. et al. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27, 35-48 (2007).
39. Xiao, C. et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9, 405-414 (2008).
40. Kuchen, S. et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32, 828-839 (2010).
41. Sze, D. M., Toellner, K. M., Garcia,d, V., Taylor, D. R. & MacLennan, I. C. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192, 813-821 (2000).
42. Cassese, G. et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171, 1684-1690 (2003).
43. Minges Wols, H. A., Underhill, G. H., Kansas, G. S. & Witte, P. L. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169, 4213-4221 (2002).
44. Fang, C. M. et al. Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response. Genes Immun. 13, 421-430 (2012).
45. Savitsky, D. A., Yanai, H., Tamura, T., Taniguchi, T. & Honda, K. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc. Natl Acad. Sci. USA 107, 10154-10159 (2010).
46. Coutelier, J. P., van der Logt, J. T., Heessen, F. W., Warnier, G. & Van Snick, J. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165, 64-69 (1987).
47. Kipps, T. J., Parham, P., Punt, J. & Herzenberg, L. A. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J. Exp. Med. 161, 1-17 (1985).
48. Nimmerjahn, F. & Ravetch, J. V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310, 1510-1512 (2005).
49. Fossati-Jimack, L. et al. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J. Exp. Med. 191, 1293-1302 (2000).
50. Arnon, T. I. et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science 333, 1898-1903 (2011).
51. Ye, B. H. et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16, 161-170 (1997).
52. Xu, S., Huo, J., Lee, K. G., Kurosaki, T. & Lam, K. P. Phospholipase Cgamma2 is critical for Dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells. J. Biol. Chem. 284, 7038-7046 (2009).
53. Matsui, T. et al. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 464, 927-931 (2010).